Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital

To assess use of bone-targeting agents (BTA) in patients with confirmed bone metastases (BM) from breast cancer (BC), non-small cell lung cancer (NSCLC) or prostate cancer (PC). DESIGN: Retrospective cohort study. SETTING: Regional hospital-based oncology database of approximately 2 million patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Seesaghur, Anouchka, Egger, Peter, Warden, Joshua, Abbasi, Ali, Levick, Bethany, Riaz, Majid, McMahon, Peter, Thompson, Matthew, Cheeseman, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410833/
https://www.ncbi.nlm.nih.gov/pubmed/37156580
http://dx.doi.org/10.1136/bmjopen-2022-069214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410833/
https://www.ncbi.nlm.nih.gov/pubmed/37156580
http://dx.doi.org/10.1136/bmjopen-2022-069214

Ejemplares similares